| HOME >> MEDICINE >> TECHNOLOGY |
(77.2)(70.3)Purchase of treasury shares
(300.0)(269.8)Net cash used in financing activities-continuing operations
(381.3)(344.2)Net cash provided by financing activities-discontinued operations
--Net cash used in financing activities
(381.3)(344.2)Net increase/(decrease) in cash and equivalents
81.3(43.1)Cash and equivalents at beginning of period
1,929.32,755.3Cash and equivalents at end of period
$ 2,010.6$
2,712.2Schedule 4CARDINAL HEALTH, INC. AND SUBSIDIARIESBUSINESS ANALYSISTOTAL COMPANYNon-GAAPFirst QuarterFirst Quarter(in millions)2012201120122011RevenueAmount
$ 26,792$ 24,438Growth Rate
10 %(1)%Operating EarningsAmount
$
412$
364$ 442$
382Growth Rate
13 %52 %16 %17 %Earnings from Continuing OperationsAmount
$
237$
294$ 256$
231Growth Rate
(19)%N.M.11 %18 %Refer to the GAAP/Non-GAAP Reconciliation for definitions and calculations supporting the Non-GAAP balances.Schedule 5CARDINAL HEALTH, INC. AND SUBSIDIARIESSEGMENT BUSINESS ANALYSISFirst QuarterFirst Quarter(in millions)20122011(in millions)20122011PHARMACEUTICALMEDICALRevenueRevenueAmount
$ 24,418$ 22,273Amount
$ 2,380$
2,169Growth Rate
10 %(1)%Growth Rate
10 %(3)%Mix
91 %91 %Mix
9 %9 %Segment ProfitSegment ProfitAmount
$
363$
306Amount
$
79$
84Growth Rate
19 %45 %Growth Rate
(5)%(27)%Mix
82 %79 %Mix
18 %21 %Segment Profit Margin
1.49 %1.37 %Segment Profit Margin
3.32 %3.85 %Refer to definitions for an explanation of calculations.Total consolidated revenue for the three months ended September 30, 2011 was $26,792 million, which included total segment revenue of $26,798 million and Corporate revenue of $(6) million. Total consolidated revenue for the three months ended Septembe
'/>"/>
| SOURCE Cardinal Health Copyright©2010 PR Newswire. All rights reserved |